Search
Add filters:
Use filters to refine the search results.
Item hits:
| Issue Date | Title | Author(s) |
|---|---|---|
| 13-Nov-2020 | Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2 | Kudo, Masatoshi; Galle, Peter R.; Brandi, Giovanni; Kang, Yoon Koo; Yen, Chia Jui; Finn, Richard S.; Llovet i Bayer, Josep Maria; Assenat, Eric; Merle, Philippe; Chan, Stephen L.; Palmer, Daniel H.; Ikeda, Masafumi; Yamashita, Tatsuya; Vogel, Arndt; Huang, Yi Hsiang; Abada, Paolo; Yoshikawa, Reigetsu; Shinozaki, Kenta; Wang, Chunxiao; Widau, Ryan C.; Zhu, Andrew X. |
| 14-Nov-2020 | Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab | Reig, María; Galle, Peter R.; Kudo, Masatoshi; Finn, Richard; Llovet i Bayer, Josep Maria; Metti, Andrea L.; Schelman, William R.; Liang, Kun; Wang, Chunxiao; Widau, Ryan C.; Abada, Paolo; Zhu, Andrew X. |
| 31-Mar-2019 | Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival | Llovet i Bayer, Josep Maria; Montal, Robert; Villanueva, Augusto |
| 24-Jun-2021 | Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. | Craig, Amanda J.; Garcia-Lezana, Teresa; Ruiz de Galarreta, Marina; Villacorta-Martin, Carlos; Kozlova, Edgard G; Martins-Filho, Sebastiao N.; von Felden, Johann; Ahsen, Mehmet Eren; Bresnahan, Erin; Hernandez Meza, Gabriela; Labgaa, Ismail; D'Avola, Delia; Schwartz, Myron; Llovet i Bayer, Josep Maria; Sia, Daniela; Thung, Swan N.; Losic, Bojan; Lujambio, Amaia; Villanueva, Augusto |
| 1-Aug-2020 | Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications | Carrillo Reixach, Juan; Torrens, Laura; Simon Coma, Marina; Royo, Laura; Domingo Sàbat, Montserrat; Abril Fornaguera, Jordi; Akers, Nicholas; Sala, Margarita; Ragull, Sonia; Arnal, Magdalena; Villalmanzo, Núria; Cairo, Stefano; Villanueva Garatachea, Alberto; Kappler, Roland; Garrido, Marta; Guerra, Laura; Sabado, Constantino; Guillén, Gabriela; Mallo, Mar; Piñeyro, David; Vázquez Vitali, María; Kuchuk, Olga; Mateos, María Elena; Ramírez, Gema; López Santamaría, Manuel; Mozo, Yasmina; Soriano, Aroa; Grotzer, Michael; Branchereau, Sophie; García de Andoin, Nagore; López Ibor, Blanca; López Almaraz, Ricardo; Salinas, José Antonio; Torres, Bárbara; Hernández, Francisco; Uriz, José Javier; Fabre, Monique; Blanco, Julià; Paris, Claudia; Bajciová, Viera; Laureys, Geneviève; Masnou, Helena; Clos, Ariadna; Belendez, Cristina; Guettier, Catherine; Sumoy, Lauro; Planas, Ramón; Jordà Ramos, Mireia; Nonell, Lara; Czauderna, Piotr; Morland, Bruce; Sia, Daniela; Losic, Bojan; Buendia, Marie Annick; Sarrias Fornés, Maria Rosa; Llovet i Bayer, Josep Maria; Armengol, Carolina |
| 7-Jan-2019 | Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC | Pinyol, Roser; Sia, Daniela; Llovet i Bayer, Josep Maria |
| 15-Jan-2020 | Intratumoral heterogeneity and clonal evolution in liver cancer | Losic, Bojan; Craig, Amanda J.; Villacorta-Martin, Carlos; Martins-Filho, Sebastiao N.; Akers, Nicholas; Chen, Xintong; Ahsen, Mehmet Eren; von Felden, Johann; Labgaa, Ismail; Avola, Delia D'; Allette, Kimaada; Lira, Sergio A.; Furtado, Glaucia C.; Garcia-Lezana, Teresa; Restrepo, Paula; Stueck, Ashley; Ward, Stephen C.; Fiel, Maria I.; Hiotis, Spiros P.; Gunasekaran, Ganesh; Sia, Daniela; Schadt, Eric E.; Sebra, Robert; Schwartz, Myron; Llovet i Bayer, Josep Maria; Thung, Swan N.; Stolovitzky, Gustavo; Villanueva, Augusto |
| Aug-2020 | Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2 | Kudo, Masatoshi; Galle, Peter R.; Llovet i Bayer, Josep Maria; Finn, Richard S.; Vogel, Arndt; Motomura, Kenta; Assenat, Eric; Merle, Philippe; Brandi, Giovanni; Daniele, Bruno; Okusaka, Takuji; Tomášek, Jiří; Borg, Christophe; Dadduzio, Vincenzo; Morimoto, Manabu; Pracht, Marc; Jen, Min-Hua; Widau, Ryan C.; Shinozaki, Kenta; Yoshikawa, Reigetsu; Zhu, Andrew X. |
| 14-Nov-2016 | Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma | Bollard, Julien; Miguela, Verónica; Ruiz de Galarreta, Marina; Venkatesh, Anu; Bian, C. Billie; Roberto, Mark P.; Tovar, Victoria; Sia, Daniela; Molina Sánchez, Pedro; Nguyen, Christie B.; Nakagawa, Shigeki; Llovet i Bayer, Josep Maria; Hoshida, Yujin; Lujambio, Amaia |
| Jun-2015 | DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma | Villanueva, Augusto; Portela, Anna; Sayols, Sergi; Battiston, Carlo; Hoshida, Yujin; Méndez González, Jesús; Imbeaud, Sandrine; Letouzé, Eric; Hernández Gea, Virginia; Cornella, Helena; Pinyol, Roser; Solé Arqués, Manuel; Fuster Obregón, Josep; Zucman-Rossi, Jessica; Mazzaferro, Vincenzo; Esteller, Manel; Llovet i Bayer, Josep Maria; HEPTROMIC Consortium |
Discover
Subject